CellSight Technologies is a molecular imaging company. It aims to discover, develop, and commercialize positron emission tomography (PET) imaging companion diagnostics for the development of therapies and the clinical management of patients. CellSight's PET tracer VisAcT can help determine whether a patient's immune system is responding appropriately to their immunotherapy regimen.